First post on this site.....

Curious as to what DM will have to say on the Zenith webcast tomorrow. I doubt he will discuss RVX and I imagine that it will mostly likely be to put a positive spin on less than spectacular progress at Zenith and hence the departure of Julie C. Could be wrong, here's hoping.

I guess there is an outside chance that DM actually is seriously talking to a buyer who is interested in a deal that re-unites all the IP as that might make a nice epigenetic platform for a pharma. In that instance Julie C. might have found herself in a position that was less than full steam ahead and she was not interested in being a "caretaker" president. As I said, a longshot and we would never hear about it until after the fact.

I think we are likely in a holding pattern with RVX until the official announcement of ph3